Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis (Q34276710)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

(4Z,7Z,10Z,13Z,15E,17S)-17-hydroxydocosapentaenoic acid

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

author name string

Cheng-Ying Chiu

1

1 reference

Europe PubMed Central

1 August 2017

Beate Gomolka

2

1 reference

Europe PubMed Central

1 August 2017

Cordula Dierkes

3

1 reference

Europe PubMed Central

1 August 2017

Nora R Huang

4

1 reference

Europe PubMed Central

1 August 2017

Maik Schroeder

5

1 reference

Europe PubMed Central

1 August 2017

Martin Purschke

6

1 reference

Europe PubMed Central

1 August 2017

Dieter Manstein

7

1 reference

Europe PubMed Central

1 August 2017

Bindi Dangi

8

1 reference

Europe PubMed Central

1 August 2017

Karsten H Weylandt

9

1 reference

Europe PubMed Central

1 August 2017

publication date

23 May 2012

1 reference

Europe PubMed Central

1 August 2017

Inflammation Research

1 reference

Europe PubMed Central

1 August 2017

61

1 reference

Europe PubMed Central

1 August 2017

9

1 reference

Europe PubMed Central

1 August 2017

967-976

1 reference

Europe PubMed Central

1 August 2017

https://scigraph.springernature.com/pub.10.1007/s00011-012-0489-8

0 references

Resolution of inflammation: state of the art, definitions and terms

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Resolution of inflammation: the beginning programs the end

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6).

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6).

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

The chemokine system in diverse forms of macrophage activation and polarization

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Alternative activation of macrophages: an immunologic functional perspective

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Alternative versus classical activation of macrophages.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Other functions, other genes: alternative activation of antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

The many faces of macrophage activation

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Unravelling the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Inflammatory bowel disease: cause and immunobiology

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

The role of macrophages in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Lipoxin biosynthesis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Impaired phagocytosis in caveolin-1 deficient macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

A rapid and simple microfluorometric phagocytosis assay

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

The interleukin-23 axis in intestinal inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

The B-cell system in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Dendritic cells in intestinal immune regulation.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Resolvins and protectins in inflammation resolution.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Alternative activation of macrophages: mechanism and functions

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS00011-012-0489-8

21 January 2018

High resolution colonoscopy in live mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental models of inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22618200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00011-012-0489-8

1 reference

Europe PubMed Central

1 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34276710&oldid=1976560663"